HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Reactive oxygen species spermine metabolites generated from amine oxidases and radiation represent a therapeutic gain in cancer treatments.

Abstract
The most frequent interventions in cancer therapy are currently the destruction of cells by irradiation or administration of drugs both able to induce radical formation and toxic metabolites by enzyme-catalyzed reactions. The aim of this study was to determine the cell viability of cells undergoing a DNA damage threshold accomplished by ROS overproduction via both ectopic expression of murine spermine oxidase (mSMOX) and bovine serum amine oxidase (BSAO) enzymes. Low dose of X-irradiation delivers a challenging dose of damage as evaluated in proficient Chinese hamster AA8 cell line and both deficient transcription-coupled nucleotide excision repair (NER) UV61 cells and deficient base excision repair (BER) EM9 cells, at 6 and 24 h after exposure. The priming dose of ROS overexposure by mSMOX provokes an adaptive response in N18TG2, AA8 and EM9 cell lines at 24 h. Interestingly, in the UV61 cells, ROS overexposure by mSMOX delivers an earlier adaptive response to radiation. The enzymatic formation of toxic metabolites has mainly been investigated on wild-type (WT) and multidrug-resistant (MDR) cancer cell lines, using and spermine as substrate of the BSAO enzyme. MDR cells are more sensitive to the toxic polyamine metabolites than WT cells, thus indicating a new therapeutic strategy to overcome MDR tumors. Since SMOX in mammals is differentially activated in a tissue-specific manner and cancer cells can differ in terms of DNA repair and MDR capabilities, it could be of interest to simultaneously treat with very low dose of X-rays and/or to alter SMOX metabolism to generate a differential response in healthy and cancer tissues.
AuthorsRoberto Amendola, Manuela Cervelli, Emiliano Fratini, Davide E Sallustio, Giampiero Tempera, Taichi Ueshima, Paolo Mariottini, Enzo Agostinelli
JournalInternational journal of oncology (Int J Oncol) Vol. 43 Issue 3 Pg. 813-20 (Sep 2013) ISSN: 1791-2423 [Electronic] Greece
PMID23857253 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Reactive Oxygen Species
  • Oxidoreductases
  • Oxidoreductases Acting on CH-NH Group Donors
  • polyamine oxidase
Topics
  • Animals
  • Cattle
  • Cell Line, Tumor
  • Cricetinae
  • Cricetulus
  • DNA Damage (genetics, radiation effects)
  • Drug Resistance, Neoplasm (genetics, radiation effects)
  • Humans
  • Mice
  • Neoplasms (etiology, metabolism, pathology)
  • Oxidoreductases (metabolism)
  • Oxidoreductases Acting on CH-NH Group Donors (metabolism)
  • Reactive Oxygen Species (metabolism)
  • X-Rays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: